According to the latest report by IMARC Group, titled, “Vaccine Adjuvants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, the global vaccine adjuvants market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 12% during 2021-2026.

Vaccine adjuvants refer to compounds that enhance the immunogenic reaction of the body against antigens that have insufficient immunostimulatory capabilities. An adjuvant refers to an ingredient that is utilized to create a stronger immune response in people receiving the vaccine. Vaccines comprise weakened or dead germs which elicit the immune response and activate antigen-presenting cells (APCs). This reaction assists the body in increasing its ability to induce long-term protection and safety against related infections. Some of the commonly available vaccine adjuvants that are feasible for human use include aluminum salts and MF59, which is an oil-in-water emulsion made up of squalene.

Get a PDF Sample for more detailed market insights:

Market Trends

The increasing prevalence of allergies and infectious diseases, such as cancer, human immunodeficiency virus (HIV/AIDS), human papillomavirus (HPV), tuberculosis, etc., is driving the vaccine adjuvants market globally. Additionally, the rising need for advanced treatment options for existing and emerging fatal diseases has resulted in the development of vaccines that have long-lasting effects on immunization, which is further catalyzing the market growth. Besides this, the improving healthcare infrastructures and the growing levels of investments in research and development (R&D) of new therapeutics are further propelling the product demand. Moreover, the sudden outbreak of the COVID-19 pandemic is escalating the requirement for effective and safe vaccine adjuvants, which is anticipated to fuel the market growth in the coming years.

NoteWe are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

  • Adjuvance Tecchnologies Inc.
  • Adjuvatis
  • Agenus Inc.
  • Brenntag SE
  • Chemtrade Logistics Inc.
  • CSL Limited
  • Croda International Plc
  • Invivogen
  • Novavax Inc.
  • OZ Biosciences
  • Virometix AG.

Vaccine Adjuvants Market Segmentation:

The report has segmented the market based on product type, route of administration, diseases and application.

Breakup by Product Type:

  • Adjuvant Emulsions
  • Pathogen Components
  • Particulate Adjuvants
  • Combination Adjuvants
  • Others

Breakup by Route of Administration:

  • Oral
  • Intramuscular
  • Intranasal
  • Subcutaneous
  • Intradermal
  • Others

Breakup by Diseases:

  • Cancer
  • Infectious Diseases
  • Others

Breakup by Application:

  • Research
  • Commercial

Breakup by Region:

  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Table of Content:

1    Preface
2    Scope and Methodology

2.1    Objectives of the Study
2.2    Stakeholders
2.3    Data Sources
2.3.1    Primary Sources
2.3.2    Secondary Sources
2.4    Market Estimation
2.4.1    Bottom-Up Approach
2.4.2    Top-Down Approach
2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

4.1    Overview
4.2    Key Industry Trends
5    Global Vaccine Adjuvants Market
5.1    Market Overview
5.2    Market Performance
5.3    Impact of COVID-19
5.4    Market Forecast
6    Market Breakup by Product Type
6.1    Adjuvant Emulsions
6.1.1 Market Trends
6.1.2 Market Forecast
6.2    Pathogen Components
6.2.1 Market Trends
6.2.2 Market Forecast
6.3    Particulate Adjuvants
6.3.1 Market Trends
6.3.2 Market Forecast
6.4    Combination Adjuvants
6.4.1 Market Trends
6.4.2 Market Forecast
6.5    Others
6.5.1 Market Trends
6.5.2 Market Forecast
7    Market Breakup by Route of Administration
7.1    Oral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2    Intramuscular
7.2.1 Market Trends
7.2.2 Market Forecast
7.3    Intranasal
7.3.1 Market Trends
7.3.2 Market Forecast
7.4    Subcutaneous
7.4.1 Market Trends
7.4.2 Market Forecast
7.5    Intradermal
7.5.1 Market Trends
7.5.2 Market Forecast
7.6    Others
7.6.1 Market Trends
7.6.2 Market Forecast
8    Market Breakup by Diseases
8.1    Cancer
8.1.1 Market Trends
8.1.2 Market Forecast
8.2    Infectious Diseases
8.2.1 Market Trends
8.2.2 Market Forecast
8.3    Others
8.3.1 Market Trends
8.3.2 Market Forecast
9    Market Breakup by Application
9.1    Research
9.1.1 Market Trends
9.1.2 Market Forecast
9.2    Commercial
9.2.1 Market Trends
9.2.2 Market Forecast
10    Market Breakup by Region
10.1    North America
10.1.1 United States Market Trends Market Forecast
10.1.2 Canada Market Trends Market Forecast
10.2    Asia-Pacific
10.2.1 China Market Trends Market Forecast
10.2.2 Japan Market Trends Market Forecast
10.2.3 India Market Trends Market Forecast
10.2.4 South Korea Market Trends Market Forecast
10.2.5 Australia Market Trends Market Forecast
10.2.6 Indonesia Market Trends Market Forecast
10.2.7 Others Market Trends Market Forecast
10.3    Europe
10.3.1 Germany Market Trends Market Forecast
10.3.2 France Market Trends Market Forecast
10.3.3 United Kingdom Market Trends Market Forecast
10.3.4 Italy Market Trends Market Forecast
10.3.5 Spain Market Trends Market Forecast
10.3.6 Russia Market Trends Market Forecast
10.3.7 Others Market Trends Market Forecast
10.4    Latin America
10.4.1 Brazil Market Trends Market Forecast
10.4.2 Mexico Market Trends Market Forecast
10.4.3 Others Market Trends Market Forecast
10.5    Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11    SWOT Analysis
11.1    Overview
11.2    Strengths
11.3    Weaknesses
11.4    Opportunities
11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

13.1    Overview
13.2    Bargaining Power of Buyers
13.3    Bargaining Power of Suppliers
13.4    Degree of Competition
13.5    Threat of New Entrants
13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

15.1    Market Structure
15.2    Key Players
15.3    Profiles of Key Players
15.3.1    Adjuvance Tecchnologies Inc. Company Overview Product Portfolio
15.3.2    Adjuvatis Company Overview Product Portfolio
15.3.3    Agenus Inc. Company Overview Product Portfolio Financials SWOT Analysis
15.3.4    Brenntag SE Company Overview Product Portfolio Financials
15.3.5    Chemtrade Logistics Inc. Company Overview Product Portfolio Financials SWOT Analysis
15.3.6    CSL Limited Company Overview Product Portfolio Financials SWOT Analysis
15.3.7    Croda International Plc Company Overview Product Portfolio Financials SWOT Analysis
15.3.8    Invivogen Company Overview Product Portfolio
15.3.9    Novavax Inc. Company Overview Product Portfolio Financials SWOT Analysis
15.3.10    OZ Biosciences Company Overview Product Portfolio
15.3.11    Virometix AG Company Overview Product Portfolio

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

30 N Gould St
Ste R
Sheridan, WY 82801
Email: [email protected]
Follow us on twitter: @imarcglobal


Please enter your comment!
Please enter your name here